The ribosome-inactivating proteins MAP30 and Momordin inhibit SARS-CoV-2.
Bitter melon proteins can inhibit SARS-CoV-2 replication and have potential for COVID-19 treatment, according to new research. Two specific proteins from bitter melon, MAP30 and Momordin, showed strong inhibition of the virus in lung cells without damaging the cells. This discovery could lead to the development of effective treatments for COVID-19.
- Watts NR et al (2023).
- PLoS One.
- PubMed:
- 37384752